Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Clinical trial NCT06801834 · RECRUITING

Trial details

NCT number: NCT06801834
Sponsor: Gilead Sciences
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2025-04-04
Primary completion: 2029-10-01
Enrollment: 695

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.